Benoit H. Mulsant, MD, MS
Institute of Medical Science, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Department of Psychiatry, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; The Royal Hospital, Ottawa, Ontario, Canada
Meta-Analysis
Effect of rTMS on Suicidal Ideation in Treatment-Resistant Depression
January 18, 2022
Repetitive magnetic transcranial stimulation (rTMS) has been established as an efficacious treatment for MDD. This meta-analysis looked at its effects on suicidal ideation in depressed patients across the lifespan.
Original Research
Continuation MST for Treatment-Resistant Depression
October 19, 2021
Magnetic seizure therapy (MST) has shown promise as an alternative to electroconvulsive therapy for acute treatment-resistant depression (TRD). This study examines the efficacy of MST as a continuation treatment...
Original Research
Benzodiazepines in Older Adults Receiving Antidepressants for Anxiety and Depression
September 29, 2020
This analysis of data from 2 clinical trials examined the effect of benzodiazepines on outcomes in older patients with generalized anxiety disorder or major depressive disorder, including the likelihood...
Original Research
Predictors of Extrapyramidal Symptoms With Aripiprazole in Late-Life Depression
June 19, 2018
Augmentation of antidepressants with aripiprazole is effective in treating late-life depression. As an antipsychotic medication, however, aripiprazole potentially leads to extrapyramidal side effects (EPS). Read this article to learn...
Original Research
Executive Function Predicts Antidepressant Treatment Noncompletion in Late-Life Depression
April 3, 2018
Impaired executive function often accompanies depression in older adults. Can executive dysfunction lead to decreased response to antidepressant treatment? Read this article to learn more about the relationship between...
